|
Invited Speakers:
|
|
Sonia BEKEN
Master in Biological Sciences and Ph.D. in Pharmaceutical Sciences, non-clinical assessor, Belgian Medicines Commission, Federal Public Service Health, Food Chain Safety and EnvironmentHilde BOONE
Pharmacist and industrial pharmacist, UIA, Regulatory Affairs sector EMEA, London Stéphane CALLEWAERT
M.Sc, Molecular Biology, ULB, Manager Worldwide Vaccine Registration, GSK Biologicals Isabelle de ZEGHER
M.D., UCL, M.Sc., Stanford University, Global Account Manager Cd & MA, Novartis Pharma Anne-Marie GEORGES
Ph.D., Independent Consultant, Chairperson of the Regulatory Affairs Working Group of European Vaccine Manufacturers Association Anne HEPBURN
Ph.D. in Medical Biology, ULB, Regulatory Affairs Department, GSK Biologicals Paul LACANTE
M.D., Medical Director, Bristol-Myers Squibb Belgium André LHOIR
M.D., Medical Assessor, Belgian Medicines Commission, Federal Public Service Health, Food Chain Safety and Environment, Member of the Committee for Orphan Medicinal Products Michèle SANGELEER
M.D., ULB, Medical information & Pharmacovigilance Manager, Eli Lilly Benelux
Hilde TROUILLARD
Pharmacist and hospital pharmacist, VUB, managing pharmacist, Directorate-General Public Health Protection : Medicinal Products, Federal Public Service Health, Food Chain Safety and Environment André VANDENBERGHE
M.D., ULB, Medical Information Department, University Hospital Charleroi Dirk VANDER MIJNSBRUGGE
M.D., KUL, MBA, Vlerick School for Management, Medical Director, Pfizer Belgium Robert VANDER STICHELE
M.D., R.U.G. and V.U.B., Senior Researcher, Health Technology Assessment, Heymans Institute of Pharmacology and Belgian Health Care Council Els VERSCHAEREN
Pharmacist and hospital pharmacist, KUL, managing pharmacist, Directorate-General Public Health Protection : Medicinal Products, Federal Public Service Health, Food Chain Safety and Environment
|
|